Prasugrel in Comparison to High Clopidogrel Dose for Inhibition of Platelet Reactivity as Assessed With a Point-of-Care Platelet Function Assay in Patients Undergoing Chronic Hemodialysis Presenting Resistance to the Usual Clopidogrel Dose
Phase of Trial: Phase III
Latest Information Update: 11 Oct 2011
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Thrombosis
- Focus Pharmacodynamics; Pharmacogenomic
- 11 Oct 2011 Results published in the Journal of Thrombosis and Haemostasis.
- 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
- 15 Nov 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History